Terms: = Bone cancer AND LCP1, CP64, 3936, ENSG00000136167, FLJ39956, DKFZp781A23186, L-PLASTIN, FLJ25423, P13796, FLJ26114, PLS2, LC64P AND Treatment
2 results:
1. lcp1 triggers mTORC2/AKT activity and is pharmacologically targeted by enzastaurin in hypereosinophilia.
Ma G; Gezer D; Herrmann O; Feldberg K; Schemionek M; Jawhar M; Reiter A; Brümmendorf TH; Koschmieder S; Chatain N
Mol Carcinog; 2020 Jan; 59(1):87-103. PubMed ID: 31691359
[TBL] [Abstract] [Full Text] [Related]
2. Cataracts among cancer survivors.
Stava C; Beck M; Vassilopoulou-Sellin R
Am J Clin Oncol; 2005 Dec; 28(6):603-8. PubMed ID: 16317272
[TBL] [Abstract] [Full Text] [Related]
